Skip to main content
AAN.com
Articles
January 1, 1998

Progressive supranuclear gaze palsy is in linkage disequilibrium with theτ and not the α-synuclein gene

January 1998 issue
50 (1) 270-273

Abstract

We studied two candidate genes, tau (τ) and α-synuclein (SNCA), for evidence of linkage disequilibrium on a group of unrelated individuals with progressive supranuclear palsy (PSP) and a group of age-matched control subjects. The τ a1 allele and the τ a1a1 genotype were overrepresented in individuals with PSP and the τ polymorphism was in linkage disequilibrium with the PSP disease locus when a recessive inheritance model was employed. We also report a lack of evidence to support linkage disequilibrium between PSP and the SNCA candidate Parkinson's disease gene on chromosome 4q21-q23.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Steele JC, Richardson JC, Olzewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
2.
Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear gaze palsy(Steele-Richardson-Olzewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996;47:1-9.
3.
Conrad C, Andreadis A, Trojanowski JQ, et al. Genetic evidence for the involvement of gt in progressive supranuclear palsy. Ann Neurol 1997;41:277-281.
4.
Lazzarini AM, Golbe LI, Dickson DW, Duviosin RC, Johnson WG. Tau intronic polymorphism in Parkinson's disease and progressive supranuclear palsy [abstract]. Neurology 1997;48(suppl):A427.
5.
Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson disease to chromosome 4q21-q23. Science 1996;274:1197-1199.
6.
Spillantini MG, Divane A, Goedert M. Assignment of humanα-synuclein (SNCA) and β-synuclein (SCNB) to chromosomes 4q21 and 5q35. Genomics 1995;27:379-381.
7.
Xia Y, Rohan de Silva HA, Rosi BL, et al. Genetic studies in Alzheimer's disease with an NACP/α-synuclein polymorphism. Ann Neurol 1996;40:207-215.
8.
Mata M, Dorovini-Zis K, Wilson M, Young AB. New form of familial Parkinson-dementia syndrome: clinical and pathologic findings. Neurology 1983;33:1439-1443.
9.
Ohara S, Kondo K, Morita H, Maruyama K, Ikeda S, Yanagisawa N. Progressive supranuclear palsy-like syndrome in two siblings of a consanguineous marriage. Neurology 1992;42:1009-1014.
10.
Gazely S, Maguire J. Familial progressive supranuclear palsy [abstract]. Brain Pathol 1994;4:534.
11.
de Yébenes JG, Sarasa JL, Daniel SE, Lees AJ. Autosomal dominant progressive supranuclear palsy: description of a pedigree and review of the literature. Brain 1995;118:1095-1103.
12.
Terwilliger JD, Ott J. Handbook of Human Genetic Linkage. Baltimore, MD: The Johns Hopkins University Press, 1994:188-210.
13.
Bell GI, Karam J, Rutter W. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci USA 1981;78:5759-5763.

Information & Authors

Information

Published In

Neurology®
Volume 50Number 1January 1998
Pages: 270-273

Publication History

Published online: January 1, 1998
Published in print: January 1998

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

J. J. Higgins, MD
From the Clinical Neurogenetics Unit, Medical Neurology Branch (Dr. Higgins, and L.T. Pho and L.E. Nee) and Neuroepidemiology Branch (Dr. Litvan), National Institute of Neurological Disorders and Stroke National Institutes of Health, Bethesda, MD; and the Laboratory of Statistical Genetics (Dr. Li), Rockefeller University, New York, NY.
I. Litvan, MD
From the Clinical Neurogenetics Unit, Medical Neurology Branch (Dr. Higgins, and L.T. Pho and L.E. Nee) and Neuroepidemiology Branch (Dr. Litvan), National Institute of Neurological Disorders and Stroke National Institutes of Health, Bethesda, MD; and the Laboratory of Statistical Genetics (Dr. Li), Rockefeller University, New York, NY.
L. T. Pho, BS
From the Clinical Neurogenetics Unit, Medical Neurology Branch (Dr. Higgins, and L.T. Pho and L.E. Nee) and Neuroepidemiology Branch (Dr. Litvan), National Institute of Neurological Disorders and Stroke National Institutes of Health, Bethesda, MD; and the Laboratory of Statistical Genetics (Dr. Li), Rockefeller University, New York, NY.
W. Li, PhD
From the Clinical Neurogenetics Unit, Medical Neurology Branch (Dr. Higgins, and L.T. Pho and L.E. Nee) and Neuroepidemiology Branch (Dr. Litvan), National Institute of Neurological Disorders and Stroke National Institutes of Health, Bethesda, MD; and the Laboratory of Statistical Genetics (Dr. Li), Rockefeller University, New York, NY.
L. E. Nee, MSW
From the Clinical Neurogenetics Unit, Medical Neurology Branch (Dr. Higgins, and L.T. Pho and L.E. Nee) and Neuroepidemiology Branch (Dr. Litvan), National Institute of Neurological Disorders and Stroke National Institutes of Health, Bethesda, MD; and the Laboratory of Statistical Genetics (Dr. Li), Rockefeller University, New York, NY.

Notes

Address correspondence and reprint requests to Dr. Joseph J. Higgins, Director, Clinical Neurogenetics, Wadsworth Center, New York State Dept. of Health, P.O. Box 509, Albany, NY 12201-0509.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype, Neurology, 56, 12, (1702-1706), (2023)./doi/10.1212/WNL.56.12.1702
    Abstract
  2. Performance on the PD test battery by relatives of patients with progressive supranuclear palsy, Neurology, 56, 1, (25-30), (2023)./doi/10.1212/WNL.56.1.25
    Abstract
  3. An extended 5′-tau susceptibility haplotype in progressive supranuclear palsy, Neurology, 55, 9, (1364-1367), (2023)./doi/10.1212/WNL.55.9.1364
    Abstract
  4. Multiple system atrophy/progressive supranuclear palsy: α-Synuclein, synphilin, tau, and APOE, Neurology, 55, 12, (1918-1920), (2023)./doi/10.1212/WNL.55.12.1918
    Abstract
  5. Mutational analysis of the tau gene in progressive supranuclear palsy, Neurology, 53, 7, (1421-1421), (2023)./doi/10.1212/WNL.53.7.1421
    Abstract
  6. The tau gene A0 allele and progressive supranuclear palsy, Neurology, 53, 6, (1219-1219), (2023)./doi/10.1212/WNL.53.6.1219
    Abstract
  7. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration, Neurology, 52, 2, (404-404), (2023)./doi/10.1212/WNL.52.2.404
    Abstract
  8. Genetics of Progressive Supranuclear Palsy: A Review, Journal of Parkinson's Disease, 11, 1, (93-105), (2021).https://doi.org/10.3233/JPD-202302
    Crossref
  9. Frontotemporal Dementia, The Cerebral Cortex in Neurodegenerative and Neuropsychiatric Disorders, (141-175), (2017).https://doi.org/10.1016/B978-0-12-801942-9.00006-9
    Crossref
  10. Atypical parkinsonism, parkinsonism-plus syndromes, and secondary parkinsonian disorders, Principles and Practice of Movement Disorders, (197-240), (2011).https://doi.org/10.1016/B978-1-4377-2369-4.00009-3
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share